Loading...

Michael A Rogawski

TitleProfessor
InstitutionUniversity of California Davis
DepartmentNeurology
AddressACC/UCDMC
CA 95817
Phone(916)801-5714
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS
    NIH/NINDS R25NS099170May 15, 2017 - Feb 28, 2022
    Role: Principal Investigator
    Training in Neurotherapeutics Discovery and Development for Academic Scientists
    NIH/NINDS R25NS077582Mar 1, 2012 - Feb 28, 2017
    Role: Principal Investigator
    Identification of novel therapeutic approaches for TETS and OP intoxication
    NIH/NINDS R21NS072094Sep 30, 2010 - Aug 31, 2013
    Role: Co-Principal Investigator
    Ion Channels in Epilepsy and as Targets for Antiepileptic Drugs
    NIH/NINDS Z01NS002732
    Role: Co-Principal Investigator
    Evaluation Of Novel Epilepsy Treatment Approaches
    NIH/NINDS Z01NS002877
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Napoli E, Schneider A, Wang JY, Trivedi A, Carrillo NR, Tassone F, Rogawski M, Hagerman RJ, Giulivi C. Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Mol Neurobiol. 2018 Sep 05. PMID: 30187385.
      View in: PubMed
    2. Dhir A, Rogawski MA. Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. Epilepsia. 2018 May; 59(5):935-944. PMID: 29682729.
      View in: PubMed
    3. Zolkowska D, Wu CY, Rogawski MA. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus. Epilepsia. 2018 Feb 17. PMID: 29453777.
      View in: PubMed
    4. Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. 2018 Jan; 59(1):37-66. PMID: 29247482.
      View in: PubMed
    5. Chen CY, Di Lucente J, Lin YC, Lien CC, Rogawski MA, Maezawa I, Jin LW. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome. Neurobiol Dis. 2018 Jan; 109(Pt A):25-32. PMID: 28927958.
      View in: PubMed
    6. Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Sci Data. 2017 05 09; 4:170061. PMID: 28485718.
      View in: PubMed
    7. Vaitkevicius H, Husain AM, Rosenthal ES, Rosand J, Bobb W, Reddy K, Rogawski MA, Cole AJ. First-in-man allopregnanolone use in super-refractory status epilepticus. Ann Clin Transl Neurol. 2017 Jun; 4(6):411-414. PMID: 28589168.
      View in: PubMed
    8. Nik AM, Pressly B, Singh V, Antrobus S, Hulsizer S, Rogawski MA, Wulff H, Pessah IN. Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye. Mol Pharmacol. 2017 Jul; 92(1):88-99. PMID: 28428226.
      View in: PubMed
    9. Lévesque M, Herrington R, Leclerc L, Rogawski MA, Avoli M. Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy. Neuropharmacology. 2017 Jul 15; 121:12-19. PMID: 28416442.
      View in: PubMed
    10. Rogawski MA. A New SV2A Ligand for Epilepsy. Cell. 2016 Oct 20; 167(3):587. PMID: 27768878.
      View in: PubMed
    11. Pessah IN, Rogawski MA, Tancredi DJ, Wulff H, Zolkowska D, Bruun DA, Hammock BD, Lein PJ. Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. Ann N Y Acad Sci. 2016 08; 1378(1):124-136. PMID: 27467073.
      View in: PubMed
    12. Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harb Perspect Med. 2016 05 02; 6(5). PMID: 26801895.
      View in: PubMed
    13. Rogawski MA. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain. 2016 Feb; 139(Pt 2):306-9. PMID: 26912516.
      View in: PubMed
    14. Desai R, Savechenkov PY, Zolkowska D, Ge RL, Rogawski MA, Bruzik KS, Forman SA, Raines DE, Miller KW. Contrasting actions of a convulsant barbiturate and its anticonvulsant enantiomer on the a1 ß3 ?2L GABAA receptor account for their in vivo effects. J Physiol. 2015 Nov 15; 593(22):4943-61. PMID: 26378885; PMCID: PMC4650410 [Available on 11/15/16].
    15. Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan; 233(2):309-23. PMID: 26525567; PMCID: PMC4703522 [Available on 01/01/17].
    16. Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. PLoS One. 2015; 10(6):e0128313. PMID: 26039057.
      View in: PubMed
    17. Bruun DA, Cao Z, Inceoglu B, Vito ST, Austin AT, Hulsizer S, Hammock BD, Tancredi DJ, Rogawski MA, Pessah IN, Lein PJ. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. Neuropharmacology. 2015 Aug; 95:332-42. PMID: 25882826; PMCID: PMC4466064.
    18. Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant. Neurotherapeutics. 2015 Jan; 12(1):234-49. PMID: 25256961; PMCID: PMC4322077.
    19. Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res. 2015 Feb; 110:189-205. PMID: 25616473.
      View in: PubMed
    20. Broomall E, Natale JE, Grimason M, Goldstein J, Smith CM, Chang C, Kanes S, Rogawski MA, Wainwright MS. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol. 2014 Dec; 76(6):911-5. PMID: 25363147; PMCID: PMC4534165.
    21. Vito ST, Austin AT, Banks CN, Inceoglu B, Bruun DA, Zolkowska D, Tancredi DJ, Rogawski MA, Hammock BD, Lein PJ. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. Toxicol Appl Pharmacol. 2014 Dec 01; 281(2):185-94. PMID: 25448683; PMCID: PMC4258121.
    22. Chen CY, Matt L, Hell JW, Rogawski MA. Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. PLoS One. 2014; 9(9):e108021. PMID: 25229608; PMCID: PMC4168215.
    23. Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. J Neurosci. 2014 Apr 23; 34(17):5765-75. PMID: 24760837.
      View in: PubMed
    24. Zolkowska D, Dhir A, Krishnan K, Covey DF, Rogawski MA. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms. Psychopharmacology (Berl). 2014 Sep; 231(17):3325-32. PMID: 24705905; PMCID: PMC4134984.
    25. Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics. 2014 Apr; 11(2):385-400. PMID: 24671870.
      View in: PubMed
    26. Inceoglu B, Zolkowska D, Yoo HJ, Wagner KM, Yang J, Hackett E, Hwang SH, Lee KS, Rogawski MA, Morisseau C, Hammock BD. Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures. PLoS One. 2013; 8(12):e80922. PMID: 24349022; PMCID: PMC3862847.
    27. Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive steroids for the treatment of status epilepticus. Epilepsia. 2013 Sep; 54 Suppl 6:93-8. PMID: 24001085; PMCID: PMC3772544.
    28. Galanopoulou AS, Kokaia M, Loeb JA, Nehlig A, Pitkänen A, Rogawski MA, Staley KJ, Whittemore VH, Dudek FE. Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia. 2013 Aug; 54 Suppl 4:13-23. PMID: 23909850; PMCID: PMC3747731.
    29. Wilcox KS, Dixon-Salazar T, Sills GJ, Ben-Menachem E, White HS, Porter RJ, Dichter MA, Moshé SL, Noebels JL, Privitera MD, Rogawski MA. Issues related to development of new antiseizure treatments. Epilepsia. 2013 Aug; 54 Suppl 4:24-34. PMID: 23909851.
      View in: PubMed
    30. Dhir A, Zolkowska D, Rogawski MA. Seizure protection by intrapulmonary delivery of midazolam in mice. Neuropharmacology. 2013 Oct; 73:425-31. PMID: 23774136.
      View in: PubMed
    31. Gasior M, Tang R, Rogawski MA. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats. J Pharmacol Exp Ther. 2013 Sep; 346(3):528-34. PMID: 23772062; PMCID: PMC3876783.
    32. Rogawski MA. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Epilepsia. 2013 May; 54 Suppl 2:33-40. PMID: 23646969.
      View in: PubMed
    33. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013 Mar; 36(3):174-84. PMID: 23298414.
      View in: PubMed
    34. Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl. 2013; (197):19-24. PMID: 23480152; PMCID: PMC4506647.
    35. Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl. 2013; (197):9-18. PMID: 23480151; PMCID: PMC4506648.
    36. Löscher W, Rogawski MA. How theories evolved concerning the mechanism of action of barbiturates. Epilepsia. 2012 Dec; 53 Suppl 8:12-25. PMID: 23205959.
      View in: PubMed
    37. Lossin C, Nam TS, Shahangian S, Rogawski MA, Choi SY, Kim MK, Sunwoo IN. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome. Neurology. 2012 Sep 04; 79(10):1033-40. PMID: 22914841.
      View in: PubMed
    38. Cao Z, Hammock BD, McCoy M, Rogawski MA, Lein PJ, Pessah IN. Tetramethylenedisulfotetramine alters Ca²? dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicol Sci. 2012 Dec; 130(2):362-72. PMID: 22889812; PMCID: PMC3529644.
    39. French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 2012 Aug 07; 79(6):589-96. PMID: 22843280; PMCID: PMC3413761.
    40. Lossin C, Shi X, Rogawski MA, Hirose S. Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiol Dis. 2012 Sep; 47(3):378-84. PMID: 22677033.
      View in: PubMed
    41. Dhir A, Rogawski MA. Role of neurosteroids in the anticonvulsant activity of midazolam. Br J Pharmacol. 2012 Apr; 165(8):2684-91. PMID: 22014182; PMCID: PMC3423249.
    42. Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 01; 21(13):2923-35. PMID: 22466801; PMCID: PMC3373240.
    43. Dhir A, Lossin C, Rogawski MA. Propofol hemisuccinate suppresses cortical spreading depression. Neurosci Lett. 2012 Apr 11; 514(1):67-70. PMID: 22390898.
      View in: PubMed
    44. Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun DA, Hammock BD, Lein PJ, Rogawski MA. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther. 2012 May; 341(2):435-46. PMID: 22328574.
      View in: PubMed
    45. Rogawski MA, Federoff HJ. Disclosure of clinical trial results when product development is abandoned. Sci Transl Med. 2011 Sep 28; 3(102):102cm29. PMID: 21957167.
      View in: PubMed
    46. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011 Mar; 11(2):56-63. PMID: 21686307; PMCID: PMC3117497.
    47. Rogawski MA. A new policy for disclosure of competing interests. Epilepsy Curr. 2011 Jan; 11(1):7-8. PMID: 21461259; PMCID: PMC3063576.
    48. Bergey GK, Rogawski MA, French J, Stafstrom CE. To Our Readers and the AES Membership. Epilepsy Curr. 2011 Jan; 11(1):7. PMID: 21461258; PMCID: PMC3063567.
    49. Noebels JL, Avoli M, Rogawski M, Olsen R, Delgado-Escueta AV. "Jasper's Basic Mechanisms of the Epilepsies" Workshop. Epilepsia. 2010 Dec; 51 Suppl 5:1-5. PMID: 21208201; PMCID: PMC4651849.
    50. Rogawski MA. Neurosteroids on the epilepsy chessboard-keeping seizures in check. Epilepsy Curr. 2010 Nov; 10(6):161-3. PMID: 21157546; PMCID: PMC3001027.
    51. Dhir A, Zolkowska D, Murphy RB, Rogawski MA. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J Pharmacol Exp Ther. 2011 Jan; 336(1):215-22. PMID: 20837991.
      View in: PubMed
    52. Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia. 2010 Aug; 51(8):1385-94. PMID: 20491877.
      View in: PubMed
    53. Reddy DS, Rogawski MA. Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy. Epilepsia. 2010; 51(Suppl 5):84. PMID: 25147407.
      View in: PubMed
    54. Fritsch B, Stott JJ, Joelle Donofrio J, Rogawski MA. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia. 2010 Jan; 51(1):108-17. PMID: 19682025; PMCID: PMC4535693.
    55. Runyon SP, Orr M, Navarro HA, Kepler JA, Rogawski MA, Kaminski RM, Cook CE. 17beta-Nitro-5alpha-androstan-3alpha-ol and its 3beta-methyl derivative: neurosteroid analogs with potent anticonvulsant and anxiolytic activities. Eur J Pharmacol. 2009 Sep 01; 617(1-3):68-73. PMID: 19577558.
      View in: PubMed
    56. Rogawski MA, Holmes GL. Nontraditional epilepsy treatment approaches. Neurotherapeutics. 2009 Apr; 6(2):213-7. PMID: 19332312.
      View in: PubMed
    57. Rogawski MA. Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics. 2009 Apr; 6(2):344-51. PMID: 19332329.
      View in: PubMed
    58. Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics. 2009 Apr; 6(2):392-401. PMID: 19332335.
      View in: PubMed
    59. Biagini G, Longo D, Baldelli E, Zoli M, Rogawski MA, Bertazzoni G, Avoli M. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia. 2009 Jan; 50 Suppl 1:53-8. PMID: 19125849; PMCID: PMC4873280.
    60. Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr. 2008 Sep-Oct; 8(5):127-30. PMID: 18852835; PMCID: PMC2566613.
    61. Rogawski MA, Bazil CW. New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep. 2008 Jul; 8(4):345-52. PMID: 18590620.
      View in: PubMed
    62. Rogawski MA. Brivaracetam: a rational drug discovery success story. Br J Pharmacol. 2008 Aug; 154(8):1555-7. PMID: 18552880; PMCID: PMC2518467.
    63. Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008 Jun; 65(6):709-14. PMID: 18541791.
      View in: PubMed
    64. Gasior M, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone does not depend upon its metabolites. Epilepsia. 2008 May; 49(5):936-7. PMID: 18454785.
      View in: PubMed
    65. Hartman AL, Lyle M, Rogawski MA, Gasior M. Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia. 2008 Feb; 49(2):334-9. PMID: 18070095.
      View in: PubMed
    66. Dudek FE, Rogawski MA. Calcium currents burst back: a possible role for dendrites in epileptogenesis. Epilepsy Curr. 2007 Sep-Oct; 7(5):140-1. PMID: 17998977; PMCID: PMC2043133.
    67. Gasior M, White NA, Rogawski MA. Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA. J Pharmacol Exp Ther. 2007 Nov; 323(2):458-68. PMID: 17717191.
      View in: PubMed
    68. Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia. 2007 Apr; 48(4):793-800. PMID: 17386058.
      View in: PubMed
    69. Rho JM, Rogawski MA. The ketogenic diet: stoking the powerhouse of the cell. Epilepsy Curr. 2007 Mar-Apr; 7(2):58-60. PMID: 17505556; PMCID: PMC1867088.
    70. Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics. 2007 Jan; 4(1):18-61. PMID: 17199015; PMCID: PMC1852436.
    71. Rogawski MA. Point-counterpoint: Do interictal spikes trigger seizures or protect against them? Epilepsy Curr. 2006 Nov-Dec; 6(6):197-8. PMID: 17260058; PMCID: PMC1783488.
    72. Rogawski MA. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res. 2006 Jun; 69(3):273-94. PMID: 16621450; PMCID: PMC1562526.
    73. Rogawski MA. Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res. 2006 Jan; 68(1):22-8. PMID: 16377151; PMCID: PMC1373807.
    74. Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr. 2005 Nov-Dec; 5(6):225-30. PMID: 16372057; PMCID: PMC1312739.
    75. Gryder DS, Castaneda DC, Rogawski MA. Evidence for low GluR2 AMPA receptor subunit expression at synapses in the rat basolateral amygdala. J Neurochem. 2005 Sep; 94(6):1728-38. PMID: 16045445; PMCID: PMC1352164.
    76. Kaminski RM, Marini H, Kim WJ, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia. 2005 Jun; 46(6):819-27. PMID: 15946323; PMCID: PMC1181535.
    77. Dudek FE, Rogawski MA. Regulation of brain water: is there a role for aquaporins in epilepsy? Epilepsy Curr. 2005 May-Jun; 5(3):104-6. PMID: 16145616; PMCID: PMC1198631.
    78. Kaminski RM, Livingood MR, Rogawski MA. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia. 2004 Jul; 45(7):864-7. PMID: 15230714.
      View in: PubMed
    79. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004 Jul; 5(7):553-64. PMID: 15208697.
      View in: PubMed
    80. Gryder DS, Rogawski MA. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci. 2003 Aug 06; 23(18):7069-74. PMID: 12904467.
      View in: PubMed
    81. Rogawski MA, Gryder D, Castaneda D, Yonekawa W, Banks MK, Lia H. GluR5 kainate receptors, seizures, and the amygdala. Ann N Y Acad Sci. 2003 Apr; 985:150-62. PMID: 12724156.
      View in: PubMed
    82. Rogawski MA. Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs? Epilepsy Behav. 2002 Dec; 3(6):493-495. PMID: 12609240.
      View in: PubMed
    83. Rogawski MA. Antiepileptogenesis by Deep Brain Stimulation. Epilepsy Curr. 2002 Sep; 2(5):153-154. PMID: 15309125.
      View in: PubMed
    84. Dudek FE, Rogawski MA. The Epileptic Neuron Redux. Epilepsy Curr. 2002 Sep; 2(5):151-152. PMID: 15309124.
      View in: PubMed
    85. Schmidt D, Rogawski MA. New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res. 2002 Jun; 50(1-2):71-8. PMID: 12151119.
      View in: PubMed
    86. Rogawski MA. New Evidence Supporting a Role for T-Type Ca(2+) Channels in Absence Epilepsy and in the Action of Ethosuximide. Epilepsy Curr. 2002 Mar; 2(2):57. PMID: 15309167.
      View in: PubMed
    Michael's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _